ID   FMO1_RAT                Reviewed;         532 AA.
AC   P36365; Q6P7Q5;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 2.
DT   24-JUL-2024, entry version 163.
DE   RecName: Full=Flavin-containing monooxygenase 1 {ECO:0000305|PubMed:8504165};
DE            EC=1.14.13.148 {ECO:0000269|PubMed:8504165};
DE            EC=1.14.13.8 {ECO:0000269|PubMed:8504165};
DE   AltName: Full=Dimethylaniline monooxygenase [N-oxide-forming] 1;
DE   AltName: Full=Dimethylaniline oxidase 1;
DE   AltName: Full=Hepatic flavin-containing monooxygenase 1;
DE            Short=FMO 1;
DE   AltName: Full=Trimethylamine monooxygenase;
GN   Name=Fmo1 {ECO:0000312|RGD:2622};
GN   Synonyms=Fmo-1 {ECO:0000303|PubMed:8504165};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8504165; DOI=10.1016/0167-4781(93)90177-f;
RA   Itoh K., Kimura T., Yokoi T., Itoh S., Kamataki T.;
RT   "Rat liver flavin-containing monooxygenase (FMO): cDNA cloning and
RT   expression in yeast.";
RL   Biochim. Biophys. Acta 1173:165-171(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 34-42 AND 52-56.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=9094723; DOI=10.1016/s0092-8674(00)80191-9;
RA   Hay J.C., Chao D.S., Kuo C.S., Scheller R.H.;
RT   "Protein interactions regulating vesicle transport between the endoplasmic
RT   reticulum and Golgi apparatus in mammalian cells.";
RL   Cell 89:149-158(1997).
CC   -!- FUNCTION: Broad spectrum monooxygenase that catalyzes the oxygenation
CC       of a wide variety of nitrogen- and sulfur-containing compounds
CC       including xenobiotics (PubMed:8504165). Catalyzes the S-oxygenation of
CC       hypotaurine to produce taurine, an organic osmolyte involved in cell
CC       volume regulation as well as a variety of cytoprotective and
CC       developmental processes (By similarity). In vitro, catalyzes the N-
CC       oxygenation of trimethylamine (TMA) to produce trimethylamine N-oxide
CC       (TMAO) and could therefore participate to the detoxification of this
CC       compound that is generated by the action of gut microbiota from dietary
CC       precursors such as choline, choline containing compounds, betaine or L-
CC       carnitine (PubMed:8504165). {ECO:0000250|UniProtKB:Q01740,
CC       ECO:0000269|PubMed:8504165}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hypotaurine + NADPH + O2 = H2O + NADP(+) + taurine;
CC         Xref=Rhea:RHEA:69819, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57783, ChEBI:CHEBI:57853,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:507393; EC=1.14.13.8;
CC         Evidence={ECO:0000250|UniProtKB:Q01740};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69820;
CC         Evidence={ECO:0000250|UniProtKB:Q01740};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hypotaurine + NADH + O2 = H2O + NAD(+) + taurine;
CC         Xref=Rhea:RHEA:74111, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57540, ChEBI:CHEBI:57853,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:507393; EC=1.14.13.8;
CC         Evidence={ECO:0000250|UniProtKB:Q01740};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:74112;
CC         Evidence={ECO:0000250|UniProtKB:Q01740};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + O2 + trimethylamine = H2O + NADP(+) + trimethylamine
CC         N-oxide; Xref=Rhea:RHEA:31979, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15724, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:58389; EC=1.14.13.148;
CC         Evidence={ECO:0000269|PubMed:8504165};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31980;
CC         Evidence={ECO:0000305|PubMed:8504165};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + N,N-dimethylaniline + NADPH + O2 = H2O + N,N-
CC         dimethylaniline N-oxide + NADP(+); Xref=Rhea:RHEA:24468,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16269, ChEBI:CHEBI:17735, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.14.13.8;
CC         Evidence={ECO:0000269|PubMed:8504165};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24469;
CC         Evidence={ECO:0000305|PubMed:8504165};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:Q01740};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=2.56 nmol/min/mg enzyme with N,N-dimethylaniline as substrate
CC         (at pH 8.4 and 37 degrees Celsius) {ECO:0000269|PubMed:8504165};
CC         Vmax=1.34 nmol/min/mg enzyme with trimethylamine as substrate (at pH
CC         8.4 and 37 degrees Celsius) {ECO:0000269|PubMed:8504165};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:8504165}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver, lung and kidney and to a lesser
CC       extent in the heart and brain. {ECO:0000269|PubMed:8504165}.
CC   -!- SIMILARITY: Belongs to the FMO family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M84719; AAA41165.1; -; mRNA.
DR   EMBL; BC061567; AAH61567.1; -; mRNA.
DR   PIR; S33758; S33758.
DR   RefSeq; NP_036924.1; NM_012792.1.
DR   RefSeq; XP_006250207.1; XM_006250145.3.
DR   RefSeq; XP_006250208.1; XM_006250146.3.
DR   AlphaFoldDB; P36365; -.
DR   SMR; P36365; -.
DR   STRING; 10116.ENSRNOP00000044613; -.
DR   iPTMnet; P36365; -.
DR   PhosphoSitePlus; P36365; -.
DR   PaxDb; 10116-ENSRNOP00000044613; -.
DR   Ensembl; ENSRNOT00000041908.4; ENSRNOP00000044613.1; ENSRNOG00000034191.5.
DR   Ensembl; ENSRNOT00055030312; ENSRNOP00055024372; ENSRNOG00055017904.
DR   Ensembl; ENSRNOT00060014962; ENSRNOP00060011608; ENSRNOG00060008910.
DR   Ensembl; ENSRNOT00065034490; ENSRNOP00065027637; ENSRNOG00065020401.
DR   GeneID; 25256; -.
DR   KEGG; rno:25256; -.
DR   UCSC; RGD:2622; rat.
DR   AGR; RGD:2622; -.
DR   CTD; 2326; -.
DR   RGD; 2622; Fmo1.
DR   eggNOG; KOG1399; Eukaryota.
DR   GeneTree; ENSGT00940000160945; -.
DR   HOGENOM; CLU_006909_8_2_1; -.
DR   InParanoid; P36365; -.
DR   OMA; VMIKEVN; -.
DR   OrthoDB; 2079054at2759; -.
DR   PhylomeDB; P36365; -.
DR   TreeFam; TF105285; -.
DR   BioCyc; MetaCyc:MONOMER-13317; -.
DR   BRENDA; 1.14.13.8; 5301.
DR   Reactome; R-RNO-1614558; Degradation of cysteine and homocysteine.
DR   Reactome; R-RNO-217271; FMO oxidises nucleophiles.
DR   SABIO-RK; P36365; -.
DR   PRO; PR:P36365; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000034191; Expressed in adult mammalian kidney and 16 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0047822; F:hypotaurine dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:RGD.
DR   GO; GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IDA:RGD.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0034899; F:trimethylamine monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0097009; P:energy homeostasis; ISO:RGD.
DR   GO; GO:0070995; P:NADPH oxidation; ISO:RGD.
DR   GO; GO:0046322; P:negative regulation of fatty acid oxidation; ISO:RGD.
DR   GO; GO:0006082; P:organic acid metabolic process; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0042412; P:taurine biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0009404; P:toxin metabolic process; ISO:RGD.
DR   GO; GO:0006805; P:xenobiotic metabolic process; ISO:RGD.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR000960; Flavin_mOase.
DR   InterPro; IPR020946; Flavin_mOase-like.
DR   InterPro; IPR002253; Flavin_mOase_1.
DR   InterPro; IPR050346; FMO.
DR   PANTHER; PTHR23023; DIMETHYLANILINE MONOOXYGENASE; 1.
DR   PANTHER; PTHR23023:SF154; DIMETHYLANILINE MONOOXYGENASE [N-OXIDE-FORMING] 1; 1.
DR   Pfam; PF00743; FMO-like; 1.
DR   PIRSF; PIRSF000332; FMO; 1.
DR   PRINTS; PR00370; FMOXYGENASE.
DR   PRINTS; PR01121; FMOXYGENASE1.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 2.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Endoplasmic reticulum; FAD; Flavoprotein;
KW   Membrane; Monooxygenase; NADP; Oxidoreductase; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..532
FT                   /note="Flavin-containing monooxygenase 1"
FT                   /id="PRO_0000147643"
FT   TOPO_DOM        1..510
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P16549"
FT   TRANSMEM        511..531
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        532
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P16549"
FT   BINDING         9..13
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         32
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         40..41
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         60..61
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         61..62
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   BINDING         195..198
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HFE4"
FT   SITE            208
FT                   /note="Important for substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P16549"
FT   CONFLICT        141
FT                   /note="D -> A (in Ref. 1; AAA41165)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   532 AA;  59825 MW;  188EABAF96653977 CRC64;
     MVKRVAIVGA GVSGLASIKC CLEEGLEPTC FERSCDLGGL WRFTEHVEEG RASLYNSVVS
     NSSKEMSCYS DFPFPEDYPN FVPNSLFLEY LQLYATQFNL LRCIYFNTKV CSITKRPDFA
     VSGQWEVVTV CQGKQSSDTF DAVMVCTGFL TNPHLPLDSF PGIQTFKGQY FHSRQYKHPD
     VFKDKRVLVV GMGNSGTDIA VEASHLAKKV FLSTTGGAWV ISRVFDSGYP WDMIFMTRFQ
     NMLRNLLPTP VVSWLISKKM NSWFNHVNYG VAPEDRTQLR EPVLNDELPG RIITGKVLIK
     PSIKEVKENS VVFNNTPKEE PIDVIVFATG YSFAFPFLDE SIVKVEDGQA SLYKYIFPAH
     LPKPTLAVIG LIKPLGSMIP TGETQARWVV QVLKGATTLP PPSVMMKEVN ERKKNKHSGF
     GLCYCKALQS DYITYIDDLL TSINAKPDLR AMLLTDPRLA LSIFFGPCTP YHFRLTGPGK
     WEGARKAILT QWDRTVNVTK TRTVQETPST FETLLKLFSF LALLVAVFFI FL
//
